Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cancer immunotherapy.

August 20, 2026 6 views

Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

Image: Phys.org

With the commercialization of mRNA vaccines against COVID-19, research and development into the application of mRNA in vaccines and pharmaceuticals is accelerating. In particular, it is attracting attention not only in vaccines for preventing infectious diseases but also in cancer immunotherapy.

Originally published at Phys.org

Share

Temporary liver coating may improve safety and targeting of mRNA vaccines and cancer therapies

'Wall-to-wall' map of NYC trees could help cool cities worldwide

Who helps more—low-income earners or the wealthy? It depends on the situation

A cell-motility pathway helps set the pace of embryo development

'Shaking up' biofilm research: Active topography reduces bacterial infections

Subscribe to our Newsletter